$4.035
0.045[1.13%]
Last update: 3:25PM Get Real Time Here
Cardiff Oncology reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cardiff Oncology using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | PM | CRDF | Q1 | -$0.25 | -$0.25 | — | — | $83.00K | $50.00K | — | — | Get Alert |
02/29/2024 | PM | CRDF | Q4 | -$0.20 | -$0.28 | -$0.21 | 25.00% | $128.00K | $40.00K | $156.00K | 290.00% | Get Alert |
11/02/2023 | PM | CRDF | Q3 | -$0.20 | -$0.28 | -$0.22 | 21.43% | $93.00K | $60.00K | $141.00K | 135.00% | Get Alert |
08/09/2023 | PM | CRDF | Q2 | -$0.24 | -$0.27 | -$0.25 | 7.41% | $91.00K | $40.00K | $108.00K | 170.00% | Get Alert |
05/04/2023 | PM | CRDF | Q1 | -$0.25 | -$0.23 | -$0.25 | -8.70% | $74.00K | $60.00K | $83.00K | 38.33% | Get Alert |
03/02/2023 | PM | CRDF | Q4 | -$0.23 | -$0.23 | -$0.20 | 13.04% | $133.00K | $70.00K | $128.00K | 82.86% | Get Alert |
11/03/2022 | PM | CRDF | Q3 | -$0.17 | -$0.26 | -$0.20 | 23.08% | $86.00K | $70.00K | $93.00K | 32.86% | Get Alert |
08/04/2022 | PM | CRDF | Q2 | -$0.17 | -$0.27 | -$0.24 | 11.11% | $68.00K | $60.00K | $91.00K | 51.67% | Get Alert |
05/05/2022 | PM | CRDF | Q1 | -$0.14 | -$0.23 | -$0.25 | -8.70% | $72.00K | $50.00K | $74.00K | 48.00% | Get Alert |
02/24/2022 | PM | CRDF | Q4 | -$0.19 | -$0.17 | -$0.23 | -35.29% | $119.00K | $40.00K | $133.00K | 232.50% | Get Alert |
11/04/2021 | PM | CRDF | Q3 | -$0.19 | -$0.17 | -$0.17 | 0.00% | $136.00K | $30.00K | $86.00K | 186.67% | Get Alert |
08/05/2021 | PM | CRDF | Q2 | -$0.51 | -$0.15 | -$0.17 | -13.33% | $43.00K | $150.00K | $68.00K | -54.67% | Get Alert |
05/06/2021 | PM | CRDF | Q1 | -$0.41 | -$0.16 | -$0.14 | 12.50% | $68.00K | $160.00K | $72.00K | -55.00% | Get Alert |
02/25/2021 | PM | CRDF | Q4 | -$0.51 | — | -$0.19 | — | $93.00K | — | $119.00K | — | Get Alert |
11/05/2020 | PM | CRDF | Q3 | -$0.71 | — | -$0.19 | — | $52.00K | — | $136.00K | — | Get Alert |
08/11/2020 | PM | CRDF | Q2 | -$0.76 | — | -$0.51 | — | $138.00K | — | $43.00K | — | Get Alert |
05/07/2020 | PM | CRDF | Q1 | -$1.02 | — | -$0.41 | — | $162.00K | — | $68.00K | — | Get Alert |
02/27/2020 | PM | CRDF | Q4 | -$1.09 | -$0.65 | -$0.51 | 21.54% | $78.00K | $60.00K | $93.00K | 55.00% | Get Alert |
11/07/2019 | PM | CRDF | Q3 | -$0.18 | — | -$0.71 | — | $88.00K | — | $52.00K | — | Get Alert |
Cardiff Oncology (CRDF) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.21, which beat the estimate of $-0.28.
The Actual Revenue was $156K, which beat the estimate of $40K.
Browse earnings estimates, EPS, and revenue on all stocks.